This HTML5 document contains 129 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.3390/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57037781
rdf:type
wikibase:Item
schema:description
article article scientifique publié en 2018 wetenschappelijk artikel im Oktober 2018 veröffentlichter wissenschaftlicher Artikel artículu científicu наукова стаття, опублікована в жовтні 2018
p:P577
wds:Q57037781-985FEB14-7716-4ED7-BC2C-34CCB947218F
wdt:P577
2018-10-03T00:00:00Z
p:P407
wds:Q57037781-023360F0-1449-4191-9729-3102639BC198
wdt:P407
wd:Q1860
p:P2860
wds:Q57037781-6FCF1F59-281A-48C9-A45B-CA463817129A wds:Q57037781-71C3160B-5A1F-4A2C-A2DA-C1AF1C987463 wds:Q57037781-7613FA11-BB65-4641-ACCA-88F1D1F7543C wds:Q57037781-872D8A6F-50DF-489A-A2BC-504B8BF4BF63 wds:Q57037781-924C002E-F816-4140-9422-2E95C5054FF5 wds:Q57037781-9D80592E-C5A7-4255-8A87-ADE17F9CCACB wds:Q57037781-9E9C6C08-17E3-412A-9F85-F10E666706C7 wds:Q57037781-A4F3A770-D3AB-4CD6-9DB3-D7350FB683E1 wds:Q57037781-A6BA5ADC-4590-4895-A9B5-A7CAD0B3B24F wds:Q57037781-AA70212C-E448-45B0-88B0-72F4C6B41CDC wds:Q57037781-1E1D979D-3B4B-4B14-B602-4FAD8E5B3E55 wds:Q57037781-235D2AF7-9D7C-4E52-A912-3F810DC8E24B wds:Q57037781-2366831F-E57E-4DBE-AF51-E99AC8B97E5C wds:Q57037781-2438F700-CDE5-4442-8368-4826C920C9E2 wds:Q57037781-288BA352-FB16-4129-8F5E-F0E4ED7A7ED4 wds:Q57037781-2E7AE0A6-A1B1-46BB-B803-188B1952D3E1 wds:Q57037781-55C77AA0-FC6D-4583-9F3F-08F68D799BF6 wds:Q57037781-6789BC47-3EC7-4107-94D5-0D5C5AFAF79E wds:Q57037781-67F97C2C-5F01-47EB-8010-1A409F402783 wds:Q57037781-684E8A90-0BDC-4795-84D9-CB48CDC8B15A wds:Q57037781-029D69DF-E347-484E-A1E2-49105063EDED wds:Q57037781-0647413F-B27C-4DC3-85C2-7854422F8818 wds:Q57037781-0F61CA9F-E315-4CD8-A2A5-9F74FF8D994C wds:Q57037781-1016AB5F-D116-40D6-B7E3-F7D367E23A33 wds:Q57037781-195CC465-BFA6-4344-A7AA-47E297353C5F wds:Q57037781-1B431C52-60BE-4515-A9E8-5982AF045791 wds:Q57037781-B069BAAA-5C6B-4910-90B0-4C1D8A1C16D2 wds:Q57037781-B3A6A239-6EED-4EE3-815E-A659F5385105 wds:Q57037781-B7454E30-1EE7-4340-8479-DB37F7A44279 wds:Q57037781-BE5CCE94-D41F-4486-9456-F5E955DAD046 wds:Q57037781-C935A6C8-96EA-44F8-A393-5DFCB43DA816 wds:Q57037781-CBBC7F38-3C85-4B58-A95D-72E4C06DCF20 wds:Q57037781-D18186CF-483A-43AC-9E8E-E91F5D4A8A0B wds:Q57037781-DF043924-58DE-48CC-95FB-E116D8C36302 wds:Q57037781-E65F57CD-6832-4BB0-AA5E-F3958B8D90B3 wds:Q57037781-EE82700E-CE64-4906-AA7F-E2EC799ED023 wds:Q57037781-68CBAB70-7471-46EF-B3F9-4315D31A0A13
wdt:P2860
wd:Q33609358 wd:Q52676212 wd:Q39397168 wd:Q86207642 wd:Q36168545 wd:Q38765887 wd:Q52571636 wd:Q37268405 wd:Q38691294 wd:Q35928690 wd:Q28072230 wd:Q38042210 wd:Q37242704 wd:Q47653552 wd:Q43703608 wd:Q81458421 wd:Q35861806 wd:Q21092368 wd:Q45921168 wd:Q50919971 wd:Q37301216 wd:Q33426090 wd:Q34279602 wd:Q34051864 wd:Q44277894 wd:Q37353810 wd:Q55037888 wd:Q74601008 wd:Q86748291 wd:Q36258733 wd:Q36306577 wd:Q36246213 wd:Q39871580 wd:Q43237199 wd:Q28534696 wd:Q38000336 wd:Q38081777
p:P2093
wds:Q57037781-9E82C527-A08D-4C0D-BD87-4745F9848D39
wdt:P2093
Ronald McDowell
rdfs:label
Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron
skos:prefLabel
Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron
schema:name
Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron
p:P50
wds:Q57037781-071FF118-8A92-4623-ACE0-259D64B3DC07 wds:Q57037781-2669B722-F765-4CC1-B0A5-4D17E44FC7D2 wds:Q57037781-2F03F535-47B0-4517-B16D-5BBA1BB25428
wdt:P50
wd:Q59688077 wd:Q28359600 wd:Q38523513
p:P1476
wds:Q57037781-B5FAA727-863D-48D9-BF0A-2C5FB33561E3
wdt:P1476
Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron
p:P304
wds:Q57037781-3F915B66-C684-481C-90F5-233FB7C71A8E
wdt:P304
320
p:P31
wds:Q57037781-8BBB8BD1-AF6F-4821-9496-4476CFE7FF57
wdt:P31
wd:Q13442814
p:P921
wds:Q57037781-D5B2DFF0-3ADF-49C1-A737-BC0E6277F820 wds:Q57037781-C52F099D-6F9B-458E-9A16-E4ACFAA5AFF2 wds:Q57037781-90F3A2B2-6564-482F-9CAB-76E6E9816664
wdt:P921
wd:Q39046682 wd:Q15724462 wd:Q3775699
p:P698
wds:Q57037781-5851CE25-2F4F-4AB0-B02F-C78C40D71565
wdtn:P698
n12:30282903
wdt:P698
30282903
p:P1433
wds:Q57037781-965346A9-EB88-451C-8BC4-364C1A637EDE
wdt:P1433
wd:Q27724774
p:P433
wds:Q57037781-35756C41-D317-4ADB-878B-9DB1E2AAF270
p:P478
wds:Q57037781-CE69FD06-831F-4D07-B334-E66225EAC641
wdt:P433
10
wdt:P478
7
p:P356
wds:Q57037781-14529B03-899B-4D50-98D7-C04D7F3ADCC5
wdtn:P356
n11:JCM7100320
wdt:P356
10.3390/JCM7100320
p:P275
wds:Q57037781-162aa3fd-2c0e-4cdc-bc73-be35e33b4cab
p:P6216
wds:Q57037781-d723c4af-3175-4d4a-85be-8fe821511514
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P932
wds:Q57037781-5DCC6F0E-C00F-4982-85C4-59969492C176
wdt:P932
6210595